Rhodes Pharmaceuticals company information, Employees & Contact Information

Trump's pharma tariffs on hold amid administration's effort to secure pricing concessions, industry investment: Stat Fierce Pharma

SCHOTT Pharma Launches Next Gen Polymer Syringe System Contract Pharma

Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update Business Wire

After recall, Pfizer warns of 'near-term stock out' of penicillin product used to treat syphilis in pregnant women Fierce Pharma

Mapi Pharma is Seeking New Depot Product Partnerships GlobeNewswire

Top 20 Pharma and BioPharma Companies Archives Contract Pharma

Pint Pharma Announces ANVISA’s Approval of BESREMi® (ropeginterferon alfa-2b) for the Treatment of Polycythemia Vera Business Wire

SILI PHARMA contains hidden drug ingredient fda.gov

EyePoint Investor Relations EyePoint Pharmaceuticals

Global Biotechnology Company Global Biotechnology Company

ONO begins Airing New Commercial “Rising to the challenges of Immuno-Oncology” in Japan ono-pharma.com

2024 drug approvals: Small companies loom large with several key FDA nods Fierce Pharma

Vetter Pharma International Contract Pharma

JPM25: After taking the wheel at Acadia, CEO Catherine Owen Adams looks to steer firm toward $1B in sales Fierce Pharma

Adragos Pharma Acquires Swiss Sterile Fill-Finish Firm Baccinex Contract Pharma

Two-thirds of top 20 pharmas have banned ChatGPT—and many in life sci call AI 'overrated,' survey finds Fierce Pharma

Pharmas are underutilizing social media to communicate with doctors and patients, HCPs say Fierce Pharma

Takeda details another round of layoffs in Massachusetts as restructuring drive rolls on Fierce Pharma

Sumitomo Pharma, suffering from sliding sales, lays off another 400 US staffers Fierce Pharma

As Vyvanse generics bite, Takeda sets out on $900M restructuring plan Fierce Pharma

The top 10 pharma drug ad spenders for 2022 Fierce Pharma

West Pharmaceutical Services Opens New Office & Warehouse Facility in Seoul Contract Pharma

Medicines From Purdue purduepharma.com

Clovis sells off remaining assets—including cancer drug Rubraca—for $70M-plus Fierce Pharma

Mapi Pharma Announces First Patient Recruited in Phase-I/II Study of Cariprazine Depot Once Monthly Injection Yahoo Finance

Recro Pharma rebrands itself as Societal CDMO in wake of Irisys purchase Fierce Pharma

MaaT Pharma Secures €37.5 Million Loan From European Investment Bank (EIB) Marking a New Step in Advancing its Clinical Program in Hemato-Oncology Yahoo Finance

Breakeven On The Horizon For Evoke Pharma, Inc. (NASDAQ:EVOK) Yahoo Finance

Pharmaceutical Aptar

Horus Pharma Pushes Ahead With Its European Expansion Yahoo Finance

ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand Reach of neffy® (epinephrine nasal spray) to Additional U.S. Pediatricians Yahoo Finance

Boehringer Ingelheim and LEO Pharma Enter Partnership to Commercialize and Further Develop SPEVIGO® (spesolimab) Yahoo Finance

LEO Pharma Closes Deal for Spevigo® Yahoo Finance

LEO Pharma presents two late-breaking abstracts for temtokibart reporting positive Phase 2b efficacy, safety and biomarker results in moderate-to-severe atopic dermatitis at the 2025 EADV Annual Meeting in Paris Yahoo Finance

CRO Industry Report Contract Pharma

Lumos Pharma Enters into Definitive Merger Agreement with Double Point Ventures to Go Private via a Tender Offer of $4.25 Cash per Share Plus Contingent Value Rights (CVR) Yahoo Finance

After triumphant pilot, GSK eyes 'digital twins' to fine-tune vaccine production, development Fierce Pharma

Coriolis Pharma Opens New Laboratory at Spark Life Science Campus in Morrisville, North Carolina Biotech Newswire

LEO Pharma Announces Positive 16-Week Interim Results for ADHAND Trial for Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis on the Hands who are Candidates for Systemic Therapy Yahoo Finance

Brenus Pharma Publishes Promising Proof of Concept Results of their Therapeutic Platform in the Scientific Frontiers in Oncology Journal. (1) Business Wire

SK Capital buys generics producer Apotex, troubled since the murder of founder Barry Sherman Fierce Pharma

Coriolis Pharma launches U.S. entity alongside innovative drug product platform service offerings for monoclonal antibodies PR Newswire

Coriolis Pharma Appoints Peter Sölkner to Board of Directors to Support the Company’s Growth Ambitions Biotech Newswire

LEO Pharma announces Positive Topline Phase 2b Results for Temtokibart in Moderate-to-Severe Atopic Dermatitis Yahoo Finance

Recordati to acquire EUSA Pharma for €750m, gaining 4 rare cancer drugs Fierce Pharma

Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases Business Wire

Pint Pharma Announces INVIMA’s Approval of ORLADEYO® (berotralstat), the First Oral Therapy for Preventing Hereditary Angioedema (HAE) Attacks in Patients Aged 12 and Older in Colombia Business Wire

Knight Therapeutics and Sumitomo Pharma enter into GlobeNewswire

Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals GlobeNewswire

Pint Pharma Announces the Approval of ORLADEYO® (berotralstat), the First Oral Therapy Indicated for Preventing Hereditary Angioedema (HAE) Attacks in Adult and Pediatric Patients Aged 12 and Older in Brazil Business Wire

MaaT Pharma Advances Toward Commercialization And Submits Marketing Authorization Application to the European Medicines Agency (EMA) for Xervyteg® (MaaT013) in Acute Graft-versus-Host Disease Business Wire

NEUWAY Pharma Appoints Dr Oliver Ernst as Chief Executive Officer and Dr Thomas Christoph as Chief Development Officer Business Wire

Yingli Pharma Doses First US Patient in Phase 1 Study of YL-13027 for Patients with Advanced Solid Tumors GlobeNewswire

PDC*line Pharma and Partners Receive €8.1M From Walloon Region and Wallonia Health Cluster BioWin for Personalized Therapeutic Vaccine Project Business Wire

Pint Pharma announces the approval of ORLADEYO® (berotralstat), the first oral therapy indicated to prevent hereditary angioedema (HAE) attacks in adults and children 12 years and older in Peru. Business Wire

Love Pharma Inc., Announces Listing on Frankfurt Stock Exchange Investing News Network

Big Pharma and Medical Device Manufacturers: Lawsuits, Recalls & Corporate Negligence Drugwatch.com

LOVE PHARMA INC. ANNOUNCES CHANGE OF NAME TO “JOLT HEALTH GlobeNewswire

F.P.S. Food and Pharma Systems Srl European Pharmaceutical Review

Sunovion Pharmaceuticals Inc. to Divest Xopenex® (levalbuterol HCI) Inhalation Solution (IS) to Akorn, Inc. Fierce Pharma

LEO Pharma appoints new Chief Financial Officer and Executive Vice President Via Ritzau

GILEAD AND LEO PHARMA ENTER INTO STRATEGIC PARTNERSHIP TO ACCELERATE DEVELOPMENT OF ORAL STAT6 PROGRAM WITH POTENTIAL IN MULTIPLE INFLAMMATORY DISEASES Via Ritzau

LEO Pharma A/S appoints Brian Hilberdink new President of LEO Pharma Inc. United States Via Ritzau

MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising t PharmiWeb.com

Gland Pharma Ltd soars 0.08%, gains for fifth straight session Business Standard

Celtic Pharma targets $1.5bn for drug makers Financial News London

LEO Pharma strengthens global leadership team with appointment of new EVP People & Communications Via Ritzau

Olivier Bohuon elected to LEO Pharma’s Board of Directors Via Ritzau

Birgitta Stymne Göransson elected member of LEO Pharma’s Board of Directors Via Ritzau